Heather Loring
Associate Director - Search & Evaluation AstraZeneca
Seminars
Tuesday 2nd February 2027
From Nose-to-Brain Theory to Clinical Success: Building a Development Strategy That Investors, Regulators, & Partners Will Support
1:00 pm
This highly practical workshop is designed for teams looking to understand what separates successful intranasal development programs from those that fail. Through open discussion, attendees will explore how to build robust development strategies that generate confidence among investors, partners, regulators, and future commercial stakeholders.
Discussion Areas:
- What evidence convinces investors to fund intranasal programs to de-risk programs?
- Understanding reimbursement and commercialization requirements and avoiding common development
- Understand how large pharma evaluates emerging intranasal technologies, platforms, and therapeutic programs when considering partnership or licensing opportunities
- Identify the scientific, clinical, and regulatory milestones that increase confidence and help transform promising innovation into a commercially attractive asset
- Learn how developers can reduce perceived development risk, strengthen differentiation, and build
